Dr. Wu was awarded her medical degree from Norman Bethune College of Medicine Jilin University in China and her Ph.D. degree from Tokyo Medical & Dental University in Japan studying skin fibrosis of Scleroderma in the original laboratory that developed bleomycin-induced skin fibrosis animal model in SSc. She continued her research of skin fibrosis in SSc as a postdoctoral fellow at Northwestern University Feinberg School of Medicine at Chicago and at the University of Texas Health Science Center at Houston. She joined the faculty as an instructor of Medicine in 2012 and became an assistant professor in 2014.
Dr. Wu’s research area is the longstanding focus on elucidating the molecular basis and pathological mechanism of SSc, specifically, type I interferon and its downstream signaling pathways in the development and progression of autoimmune disease including in its related animal models. With this research program, she was awarded The Mark Flapan Award from Scleroderma Foundation and is also currently funded by the National Institutes of Health.